Fisher Asset Management LLC Decreases Stake in Clorox Co (CLX)

Fisher Asset Management LLC lowered its position in Clorox Co (NYSE:CLX) by 1.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 31,888 shares of the company’s stock after selling 585 shares during the period. Fisher Asset Management LLC’s holdings in Clorox were worth $4,796,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of CLX. Carillon Tower Advisers Inc. boosted its stake in shares of Clorox by 82.8% in the 2nd quarter. Carillon Tower Advisers Inc. now owns 109,150 shares of the company’s stock worth $14,763,000 after buying an additional 49,450 shares during the last quarter. Berkshire Asset Management LLC PA raised its holdings in Clorox by 17.6% during the third quarter. Berkshire Asset Management LLC PA now owns 3,119 shares of the company’s stock valued at $469,000 after acquiring an additional 467 shares during the period. Victory Capital Management Inc. raised its holdings in Clorox by 0.4% during the second quarter. Victory Capital Management Inc. now owns 105,329 shares of the company’s stock valued at $14,246,000 after acquiring an additional 456 shares during the period. Homrich & Berg increased its holdings in shares of Clorox by 6.5% in the second quarter. Homrich & Berg now owns 9,021 shares of the company’s stock worth $1,220,000 after purchasing an additional 552 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. increased its holdings in shares of Clorox by 7.2% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 63,730 shares of the company’s stock worth $8,620,000 after purchasing an additional 4,281 shares during the last quarter. 78.38% of the stock is owned by institutional investors.

In other Clorox news, SVP Michael R. Costello sold 9,265 shares of the company’s stock in a transaction dated Monday, August 13th. The shares were sold at an average price of $140.02, for a total value of $1,297,285.30. Following the sale, the senior vice president now owns 34,293 shares of the company’s stock, valued at $4,801,705.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Linda J. Rendle sold 382 shares of the company’s stock in a transaction dated Thursday, September 6th. The shares were sold at an average price of $148.32, for a total transaction of $56,658.24. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 29,268 shares of company stock worth $4,196,686. Company insiders own 1.40% of the company’s stock.

Clorox stock opened at $148.45 on Thursday. The firm has a market cap of $19.51 billion, a PE ratio of 26.72, a PEG ratio of 3.65 and a beta of 0.36. Clorox Co has a 12-month low of $113.57 and a 12-month high of $155.23. The company has a debt-to-equity ratio of 3.15, a current ratio of 1.09 and a quick ratio of 0.67.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 31st. The company reported $1.62 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.59 by $0.03. The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.53 billion. Clorox had a net margin of 13.44% and a return on equity of 103.18%. Clorox’s revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period last year, the business earned $1.46 EPS. As a group, sell-side analysts forecast that Clorox Co will post 6.41 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 16th. Stockholders of record on Wednesday, October 31st will be paid a dividend of $0.96 per share. The ex-dividend date of this dividend is Tuesday, October 30th. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.59%. Clorox’s dividend payout ratio (DPR) is 61.34%.

CLX has been the topic of several analyst reports. Zacks Investment Research raised Clorox from a “hold” rating to a “buy” rating and set a $171.00 price objective on the stock in a research note on Wednesday, October 3rd. Argus upgraded Clorox from a “hold” rating to a “buy” rating and set a $175.00 price target for the company in a report on Tuesday, September 25th. UBS Group assumed coverage on Clorox in a report on Wednesday, July 18th. They issued a “sell” rating and a $110.00 price target for the company. Deutsche Bank lowered Clorox from a “hold” rating to a “sell” rating and set a $123.00 target price for the company. in a report on Wednesday, October 10th. Finally, Bank of America upped their target price on Clorox from $130.00 to $140.00 and gave the stock a “neutral” rating in a report on Monday, July 16th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and four have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $138.29.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: NASDAQ Stock Market Explained

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply